Pharmacogenetics of OPRM1

Pharmacology Biochemistry and Behavior

Volumn 123, Issue , 2014, Pages 25-33

  Crist, Richard C ^a   Berrettini, Wade H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Mu opioid receptor; OPRM1; Pharmacogenetics

Indexed keywords

ALCOHOL; ANALGESIC AGENT; MU OPIATE RECEPTOR; NICOTINE; OPIATE; OPRM1 PROTEIN, HUMAN;

ALCOHOLISM; ANALGESIA; GENE; GENETIC VARIABILITY; HUMAN; OPIATE ADDICTION; OPRM1 GENE; PAIN; PHARMACOGENETICS; PRIORITY JOURNAL; REVIEW; TOBACCO DEPENDENCE; GENETICS;

ALCOHOLISM; ANALGESIA; HUMANS; OPIOID-RELATED DISORDERS; PAIN; PHARMACOGENETICS; RECEPTORS, OPIOID, MU; TOBACCO USE DISORDER;

EID: 84905256559     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2013.10.018     Document Type: Review

References (119)

1. R. Al-Hasani, and M.R. Bruchas Molecular mechanisms of opioid receptor-dependent signaling and behavior Anesthesiology 115 6 2011 1363 1381
2. R.F. Anton, G. Oroszi, S. O'Malley, D. Couper, R. Swift, and H. Pettinati et al. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study Arch Gen Psychiatry 65 2 2008 135 144 (Pubitemid 351222547)
3. R.F. Anton, K.K. Voronin, P.K. Randall, H. Myrick, and A. Tiffany Naltrexone Modification of Drinking Effects in a Subacute Treatment and Bar-Lab Paradigm: Influence of OPRM1 and Dopamine Transporter (SLC6A3) Genes Alcohol Clin Exp Res 36 11 2012 2000 2007
4. A.J. Arias, S. Armeli, J. Gelernter, J. Covault, A. Kallio, and S. Karhuvaara et al. Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers Alcohol Clin Exp Res 32 7 2008 1159 1166
5. D.T. Barratt, J.K. Coller, R. Hallinan, A. Byrne, J.M. White, and D.J. Foster et al. ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics Pharmgenomics Pers Med 5 2012 53 62
6. G. Bart, M.J. Kreek, J. Ott, K.S. LaForge, D. Proudnikov, and L. Pollak et al. Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden Neuropsychopharmacology 30 2 2005 417 422 (Pubitemid 40129493)
7. A.W. Bergen, J. Kokoszka, R. Peterson, J.C. Long, M. Virkkunen, and M. Linnoila et al. Mu opioid receptor gene variants: lack of association with alcohol dependence Mol Psychiatry 2 6 1997 490 494
8. C. Bond, K.S. LaForge, M. Tian, D. Melia, S. Zhang, and L. Borg et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction Proc Natl Acad Sci U S A 95 16 1998 9608 9613 (Pubitemid 28506279)
9. D. Campa, A. Gioia, A. Tomei, P. Poli, and R. Barale Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief Clin Pharmacol Ther 83 4 2008 559 566 (Pubitemid 351417058)
10. A.J. Chamorro, M. Marcos, J.A. Miron-Canelo, I. Pastor, R. Gonzalez-Sarmiento, and F.J. Laso Association of micro-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis Addict Biol 17 3 2012 505 512
11. D. Chen, L. Liu, Y. Xiao, Y. Peng, C. Yang, and Z. Wang Ethnic-specific meta-analyses of association between the OPRM1 A118G polymorphism and alcohol dependence among Asians and Caucasians Drug Alcohol Depend 123 1-3 2012 1 6
12. K.I. Cheng, S.R. Lin, L.L. Chang, J.Y. Wang, and C.S. Lai Association of the functional A118G polymorphism of OPRM1 in diabetic patients with foot ulcer pain J Diabetes Complications 24 2 2010 102 108
13. W.Y. Chou, L.C. Yang, H.F. Lu, J.Y. Ko, C.H. Wang, and S.H. Lin et al. Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty Acta Anaesthesiol Scand 50 7 2006 787 792
14. J.K. Coller, S. Cahill, C. Edmonds, A.L. Farquharson, M. Longo, and R. Minniti et al. OPRM1 A118G genotype fails to predict the effectiveness of naltrexone treatment for alcohol dependence Pharmacogenet Genomics 21 12 2011 902 905
15. L. Coulbault, M. Beaussier, C. Verstuyft, H. Weickmans, L. Dubert, and D. Tregouet et al. Environmental and genetic factors associated with morphine response in the postoperative period Clin Pharmacol Ther 79 4 2006 316 324
16. S. Crettol, J. Besson, M. Croquette-Krokar, R. Hammig, I. Gothuey, and M. Monnat et al. Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment Prog Neuropsychopharmacol Biol Psychiatry 32 7 2008 1722 1727
17. J.J. Crowley, D.W. Oslin, A.A. Patkar, E. Gottheil, P.A. DeMaria Jr., and C.P. O'Brien et al. A genetic association study of the mu opioid receptor and severe opioid dependence Psychiatr Genet 13 3 2003 169 173 (Pubitemid 37082977)
18. H.A. Crystal, S. Hamon, M. Randesi, J. Cook, K. Anastos, and J. Lazar et al. A C17T polymorphism in the mu opiate receptor is associated with quantitative measures of drug use in African American women Addict Biol 17 1 2012 181 191
19. A. De Capraris, G. Cinnella, A. Marolla, P. Salatto, S. Da Lima, and P. Vetuschi et al. Micro opioid receptor A118G polymorphism and post-operative pain: opioids' effects on heterozygous patients Int J Immunopathol Pharmacol 24 4 2011 993 1004
20. I. Deb, J. Chakraborty, P.K. Gangopadhyay, S.R. Choudhury, and S. Das Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction J Neurochem 112 2 2010 486 496
21. E.F. Domino, C.L. Evans, L. Ni, S.K. Guthrie, R.A. Koeppe, and J.K. Zubieta Tobacco smoking produces greater striatal dopamine release in G-allele carriers with mu opioid receptor A118G polymorphism Prog Neuropsychopharmacol Biol Psychiatry 38 2 2012 236 240
22. J.M. Droney, S.K. Gretton, H. Sato, J.R. Ross, R. Branford, and K.I. Welsh et al. Analgesia and central side-effects: two separate dimensions of morphine response Br J Clin Pharmacol 2012
23. F.M. Filbey, E. Claus, A.R. Audette, M. Niculescu, M.T. Banich, and J. Tanabe et al. Exposure to the taste of alcohol elicits activation of the mesocorticolimbic neurocircuitry Neuropsychopharmacology 33 6 2008 1391 1401 (Pubitemid 351521721)
24. F.M. Filbey, L. Ray, A. Smolen, E.D. Claus, A. Audette, and K.E. Hutchison Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes Alcohol Clin Exp Res 32 7 2008 1113 1123
25. R.B. Fillingim, L. Kaplan, R. Staud, T.J. Ness, T.L. Glover, and C.M. Campbell et al. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans J Pain 6 3 2005 159 167 (Pubitemid 40365019)
26. P.H. Finan, A.J. Zautra, M.C. Davis, K. Lemery-Chalfant, J. Covault, and H. Tennen Genetic influences on the dynamics of pain and affect in fibromyalgia Health Psychol 29 2 2010 134 142
27. F. Fonseca, M. Gratacos, G. Escaramis, R. De Cid, R. Martin-Santos, and E. Fernandez-Espejo et al. Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes Mol Diagn Ther 14 3 2010 171 178
28. P. Franke, T. Wang, M.M. Nothen, M. Knapp, H. Neidt, and S. Albrecht et al. Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence Am J Med Genet 105 1 2001 114 119
29. P.J. Fudala, E. Yu, W. Macfadden, C. Boardman, and C.N. Chiang Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts Drug Alcohol Depend 50 1 1998 1 8 (Pubitemid 28176605)
30. K. Fukuda, M. Hayashida, S. Ide, N. Saita, Y. Kokita, and S. Kasai et al. Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery Pain 147 1-3 2009 194 201
31. K. Fukuda, M. Hayashida, K. Ikeda, Y. Koukita, T. Ichinohe, and Y. Kaneko Diversity of opioid requirements for postoperative pain control following oral surgery-is it affected by polymorphism of the mu-opioid receptor? Anesth Prog 57 4 2010 145 149
32. J. Gelernter, R. Gueorguieva, H.R. Kranzler, H. Zhang, J. Cramer, and R. Rosenheck et al. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study Alcohol Clin Exp Res 31 4 2007 555 563 (Pubitemid 46434892)
33. S.J. Glatt, C. Bousman, R.S. Wang, K.K. Murthy, B.K. Rana, and J.A. Lasky-Su et al. Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis Drug Alcohol Depend 90 2-3 2007 159 165 (Pubitemid 47299168)
34. M. Hayashida, M. Nagashima, Y. Satoh, R. Katoh, M. Tagami, and S. Ide et al. Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype Pharmacogenomics 9 11 2008 1605 1616
35. K.L. Holliday, B.I. Nicholl, G.J. Macfarlane, W. Thomson, K.A. Davies, and J. McBeth Do genetic predictors of pain sensitivity associate with persistent widespread pain? Mol Pain 5 2009 56
36. C.J. Huang, H.F. Liu, N.Y. Su, Y.W. Hsu, C.H. Yang, and C.C. Chen et al. Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females* Anaesthesia 63 12 2008 1288 1295
37. K. Huehne, S. Leis, T. Muenster, A. Wehrfritz, S. Winter, and C. Maihofner et al. High post surgical opioid requirements in Crohn's disease are not due to a general change in pain sensitivity Eur J Pain 13 10 2009 1036 1042
38. C.C. Hung, M.H. Chiou, B.H. Huang, Y.W. Hsieh, T.J. Hsieh, and C.L. Huang et al. Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients Pharmacogenomics 12 11 2011 1525 1533
39. S. Ide, W. Han, S. Kasai, H. Hata, I. Sora, and K. Ikeda Characterization of the 3′ untranslated region of the human mu-opioid receptor (MOR-1) mRNA Gene 364 2005 139 145 (Pubitemid 41773244)
40. K. Ikeda, T. Kobayashi, T. Ichikawa, T. Kumanishi, H. Niki, and R. Yano The untranslated region of (mu)-opioid receptor mRNA contributes to reduced opioid sensitivity in CXBK mice J Neurosci 21 4 2001 1334 1339 (Pubitemid 32128778)
41. B.A. Johnson Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings Biochem Pharmacol 75 1 2008 34 56 (Pubitemid 350235398)
42. J. Kakko, J. von Wachenfeldt, K.D. Svanborg, J. Lidstrom, C.S. Barr, and M. Heilig Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence Biol Psychiatry 63 2 2008 172 177 (Pubitemid 350299330)
43. S. Kapur, S. Sharad, R.A. Singh, and A.K. Gupta A118g polymorphism in mu opioid receptor gene (oprm1): association with opiate addiction in subjects of Indian origin J Integr Neurosci 6 4 2007 511 522
44. S.A. Kim, J.W. Kim, J.Y. Song, S. Park, H.J. Lee, and J.H. Chung Association of polymorphisms in nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4), mu-opioid receptor gene (OPRM1), and ethanol-metabolizing enzyme genes with alcoholism in Korean patients Alcohol 34 2-3 2004 115 120 (Pubitemid 40292768)
45. S.G. Kim, C.M. Kim, D.H. Kang, Y.J. Kim, W.T. Byun, and S.Y. Kim et al. Association of functional opioid receptor genotypes with alcohol dependence in Koreans Alcohol Clin Exp Res 28 7 2004 986 990
46. S.G. Kim, C.M. Kim, S.W. Choi, Y.M. Jae, H.G. Lee, and B.K. Son et al. A micro opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients Psychopharmacology (Berl) 201 4 2009 611 618
47. P. Klepstad, T.T. Rakvag, S. Kaasa, M. Holthe, O. Dale, and P.C. Borchgrevink et al. The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease Acta Anaesthesiol Scand 48 10 2004 1232 1239 (Pubitemid 39490855)
48. P. Klepstad, T. Fladvad, F. Skorpen, K. Bjordal, A. Caraceni, and O. Dale et al. Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients Pain 152 5 2011 1139 1145
49. G. Koller, P. Zill, D. Rujescu, M. Ridinger, O. Pogarell, and C. Fehr et al. Possible association between OPRM1 genetic variance at the 118 locus and alcohol dependence in a large treatment sample: relationship to alcohol dependence symptoms Alcohol Clin Exp Res 36 7 2012 1230 1236
50. G.F. Koob, and N.D. Volkow Neurocircuitry of addiction Neuropsychopharmacology 35 1 2010 217 238
51. H.R. Kranzler, J. Gelernter, S. O'Malley, C.A. Hernandez-Avila, and D. Kaufman Association of alcohol or other drug dependence with alleles of the mu opioid receptor gene (OPRM1) Alcohol Clin Exp Res 22 6 1998 1359 1362 (Pubitemid 28443161)
52. H.R. Kranzler, S. Armeli, J. Covault, and H. Tennen Variation in OPRM1 moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment Addict Biol 2012
53. T. Kroslak, K.S. Laforge, R.J. Gianotti, A. Ho, D.A. Nielsen, and M.J. Kreek The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor J Neurochem 103 1 2007 77 87 (Pubitemid 47404205)
54. D. Kumar, J. Chakraborty, and S. Das Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population Prog Neuropsychopharmacol Biol Psychiatry 36 2 2012 225 230
55. R. Landau, C. Kern, M.O. Columb, R.M. Smiley, and J.L. Blouin Genetic variability of the mu-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women Pain 139 1 2008 5 14
56. E.A. Laugsand, T. Fladvad, F. Skorpen, M. Maltoni, S. Kaasa, and P. Fayers et al. Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids Eur J Cancer 47 11 2011 1682 1691
57. C. Lerman, E.P. Wileyto, F. Patterson, M. Rukstalis, J. Audrain-McGovern, and S. Restine et al. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial Pharmacogenomics J 4 3 2004 184 192 (Pubitemid 38786557)
58. O. Levran, D. Londono, K. O'Hara, D.A. Nielsen, E. Peles, and J. Rotrosen et al. Genetic susceptibility to heroin addiction: a candidate gene association study Genes Brain Behav 7 7 2008 720 729
59. O. Levran, D. Londono, K. O'Hara, M. Randesi, J. Rotrosen, and P. Casadonte et al. Heroin addiction in African Americans: a hypothesis-driven association study Genes Brain Behav 8 5 2009 531 540
60. Y.C. Liu, and W.S. Wang Human mu-opioid receptor gene A118G polymorphism predicts the efficacy of tramadol/acetaminophen combination tablets (ultracet) in oxaliplatin-induced painful neuropathy Cancer 118 6 2012 1718 1725
61. W. Loh el, C.S. Fann, Y.T. Chang, C.J. Chang, and A.T. Cheng Endogenous opioid receptor genes and alcohol dependence among Taiwanese Han Alcohol Clin Exp Res 28 1 2004 15 19 (Pubitemid 38114019)
62. J. Lotsch, C. Skarke, J. Wieting, B.G. Oertel, H. Schmidt, and J. Brockmoller et al. Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action Clin Pharmacol Ther 79 1 2006 72 89 (Pubitemid 43069580)
63. J. Lotsch, N. von Hentig, R. Freynhagen, N. Griessinger, M. Zimmermann, and A. Doehring et al. Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers Pharmacogenet Genomics 19 6 2009 429 436
64. J.E. McGeary, P.M. Monti, D.J. Rohsenow, J. Tidey, R. Swift, and R. Miranda Jr. Genetic moderators of naltrexone's effects on alcohol cue reactivity Alcohol Clin Exp Res 30 8 2006 1288 1296 (Pubitemid 44114679)
65. J. Mendelson, R.T. Jones, S. Welm, M. Baggott, I. Fernandez, and A.K. Melby et al. Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers Psychopharmacology (Berl) 141 1 1999 37 46 (Pubitemid 29193293)
66. S. Menon, R.A. Lea, B. Roy, M. Hanna, S. Wee, and L.M. Haupt et al. The human mu-opioid receptor gene polymorphism (A118G) is associated with head pain severity in a clinical cohort of female migraine with aura patients J Headache Pain 13 7 2012 513 519
67. H.B. Merskey Classification of Chronic Pain Second Edition 1994 IASP Press Seattle
68. R. Miranda, L. Ray, A. Justus, L.A. Meyerson, V.S. Knopik, and J. McGeary et al. Initial evidence of an association between OPRM1 and adolescent alcohol misuse Alcohol Clin Exp Res 34 1 2010 112 122
69. R. Miranda Jr., E. Reynolds, L. Ray, A. Justus, V.S. Knopik, and J. McGeary et al. Preliminary Evidence for a Gene-Environment Interaction in Predicting Alcohol Use Disorders in Adolescents Alcohol Clin Exp Res 2012
70. M.R. Munafo, K.M. Elliot, M.F. Murphy, R.T. Walton, and E.C. Johnstone Association of the mu-opioid receptor gene with smoking cessation Pharmacogenomics J 7 5 2007 353 361 (Pubitemid 47471313)
71. M.R. Munafo, E.C. Johnstone, P. Aveyard, and T. Marteau Lack of Association of OPRM1 Genotype and Smoking Cessation Nicotine Tob Res 2012
72. D. Nagaya, S. Ramanathan, M. Ravichandran, and V. Navaratnam A118G mu opioid receptor polymorphism among drug addicts in Malaysia J Integr Neurosci 11 1 2012 117 122
73. D.A. Nielsen, and M.J. Kreek Common and specific liability to addiction: approaches to association studies of opioid addiction Drug Alcohol Depend 123 Suppl. 1 2012 S33 S41
74. M.A. Nikolov, O. Beltcheva, A. Galabova, A. Ljubenova, E. Jankova, and G. Gergov et al. No evidence of association between 118A>G OPRM1 polymorphism and heroin dependence in a large Bulgarian case-control sample Drug Alcohol Depend 117 1 2011 62 65
75. D. Nishizawa, W. Han, J. Hasegawa, T. Ishida, Y. Numata, and T. Sato et al. Association of mu-opioid receptor gene polymorphism A118G with alcohol dependence in a Japanese population Neuropsychobiology 53 3 2006 137 141 (Pubitemid 43854172)
76. E.A. Ochroch, A. Vachani, A. Gottschalk, and P.A. Kanetsky Natural variation in the mu-opioid gene OPRM1 predicts increased pain on third day after thoracotomy Clin J Pain 28 9 2012 747 754
77. B.G. Oertel, R. Schmidt, A. Schneider, G. Geisslinger, and J. Lotsch The mu-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers Pharmacogenet Genomics 16 9 2006 625 636 (Pubitemid 44223074)
78. B.G. Oertel, M. Kettner, K. Scholich, C. Renne, B. Roskam, and G. Geisslinger et al. A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain J Biol Chem 284 10 2009 6530 6535
79. B.G. Oertel, A. Doehring, B. Roskam, M. Kettner, N. Hackmann, and N. Ferreiros et al. Genetic-epigenetic interaction modulates mu-opioid receptor regulation Hum Mol Genet 21 21 2012 4751 4760
80. E. Olfson, and L.J. Bierut Convergence of genome-wide association and candidate gene studies for alcoholism Alcohol Clin Exp Res 36 12 2012 2086 2094
81. M.B. Olsen, L.M. Jacobsen, E.I. Schistad, L.M. Pedersen, L.J. Rygh, and C. Roe et al. Pain intensity the first year after lumbar disc herniation is associated with the A118G polymorphism in the opioid receptor mu 1 gene: evidence of a sex and genotype interaction J Neurosci 32 29 2012 9831 9834
82. S.S. O'Malley, S. Krishnan-Sarin, C. Farren, R. Sinha, and M.J. Kreek Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary- adrenocortical axis Psychopharmacology (Berl) 160 1 2002 19 29 (Pubitemid 34169822)
83. G. Oroszi, R.F. Anton, S. O'Malley, R. Swift, H. Pettinati, and D. Couper et al. OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach Alcohol Clin Exp Res 33 3 2009 383 393
84. D.W. Oslin, W. Berrettini, H.R. Kranzler, H. Pettinati, J. Gelernter, and J.R. Volpicelli et al. A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients Neuropsychopharmacology 28 8 2003 1546 1552 (Pubitemid 41070891)
85. K.A. Perkins, C. Lerman, A. Grottenthaler, M.M. Ciccocioppo, M. Milanak, and C.A. Conklin et al. Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood Behav Pharmacol 19 5-6 2008 641 649
86. F.D. Pettersson, A. Gronbladh, F. Nyberg, I. Sundstrom-Poromaa, and H. Akerud The A118G single-nucleotide polymorphism of human mu-opioid receptor gene and use of labor analgesia Reprod Sci 19 9 2012 962 967
87. V.A. Ramchandani, J. Umhau, F.J. Pavon, V. Ruiz-Velasco, W. Margas, and H. Sun et al. A genetic determinant of the striatal dopamine response to alcohol in men Mol Psychiatry 16 8 2011 809 817
88. L.A. Ray Stress-induced and cue-induced craving for alcohol in heavy drinkers: Preliminary evidence of genetic moderation by the OPRM1 and CRH-BP genes Alcohol Clin Exp Res 35 1 2011 166 174
89. L.A. Ray, and K.E. Hutchison A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans Alcohol Clin Exp Res 28 12 2004 1789 1795 (Pubitemid 39665194)
90. L.A. Ray, and K.E. Hutchison Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study Arch Gen Psychiatry 64 9 2007 1069 1077 (Pubitemid 47360852)
91. R. Ray, C. Jepson, F. Patterson, A. Strasser, M. Rukstalis, and K. Perkins et al. Association of OPRM1 A118G variant with the relative reinforcing value of nicotine Psychopharmacology (Berl) 188 3 2006 355 363 (Pubitemid 44387463)
92. R. Ray, C. Jepson, E.P. Wileyto, J.P. Dahl, F. Patterson, and M. Rukstalis et al. Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial Nicotine Tob Res 9 11 2007 1237 1241 (Pubitemid 350066242)
93. L.A. Ray, S. Bujarski, P.F. Chin, and K. Miotto Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study Neuropsychopharmacology 37 2 2012 445 455
94. C.C. Reyes-Gibby, S. Shete, T. Rakvag, S.V. Bhat, F. Skorpen, and E. Bruera et al. Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene Pain 130 1-2 2007 25 30 (Pubitemid 46850782)
95. R.R. Romberg, E. Olofsen, H. Bijl, P.E. Taschner, L.J. Teppema, and E.Y. Sarton et al. Polymorphism of mu-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response Anesthesiology 102 3 2005 522 530 (Pubitemid 40315140)
96. J. Shi, L. Hui, Y. Xu, F. Wang, W. Huang, and G. Hu Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin Hum Mutat 19 4 2002 459 460
97. S.D. Stockton Jr., and L.A. Devi Functional relevance of mu-delta opioid receptor heteromerization: a role in novel signaling and implications for the treatment of addiction disorders: from a symposium on new concepts in mu-opioid pharmacology Drug Alcohol Depend 121 3 2012 167 172
98. E.C. Tan, C.H. Tan, U. Karupathivan, and E.P. Yap Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations Neuroreport 14 4 2003 569 572 (Pubitemid 36528992)
99. E.C. Tan, E.C. Lim, Y.Y. Teo, Y. Lim, H.Y. Law, and A.T. Sia Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for post-operative pain Mol Pain 5 2009 32
100. J.W. Tidey, P.M. Monti, D.J. Rohsenow, C.J. Gwaltney, R. Miranda Jr., and J.E. McGeary et al. Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment Alcohol Clin Exp Res 32 1 2008 58 66 (Pubitemid 350293891)
101. F.F. Tsai, S.Z. Fan, Y.M. Yang, K.L. Chien, Y.N. Su, and L.K. Chen Human opioid mu-receptor A118G polymorphism may protect against central pruritus by epidural morphine for post-cesarean analgesia Acta Anaesthesiol Scand 54 10 2010 1265 1269
102. E. van den Wildenberg, R.W. Wiers, J. Dessers, R.G. Janssen, E.H. Lambrichs, and H.J. Smeets et al. A functional polymorphism of the mu-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers Alcohol Clin Exp Res 31 1 2007 1 10 (Pubitemid 46025359)
103. Z. Verde, C. Santiago, J.M. Rodriguez Gonzalez-Moro, P. de Lucas Ramos, S. Lopez Martin, and F. Bandres et al. 'Smoking genes': a genetic association study PLoS One 6 10 2011 e26668
104. N.D. Volkow, J.S. Fowler, R. Hitzemann, and G.J. Wang Neurochemical mechanisms underlying responses to psychostimulants NIDA Res Monogr 159 1996 322 348
105. J.R. Volpicelli, A.I. Alterman, M. Hayashida, and C.P. O'Brien Naltrexone in the treatment of alcohol dependence Arch Gen Psychiatry 49 11 1992 876 880
106. C. Walter, and J. Lotsch Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment Pain 146 3 2009 270 275
107. Z. Wang, R. Ray, M. Faith, K. Tang, E.P. Wileyto, and J.A. Detre et al. Nicotine abstinence-induced cerebral blood flow changes by genotype Neurosci Lett 438 3 2008 275 280
108. S.C. Wang, H.H. Tsou, C.H. Chen, Y.T. Chen, I.K. Ho, and C.F. Hsiao et al. Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients Eur Neuropsychopharmacol 22 10 2012 695 703
109. C.A. Wong, R.J. McCarthy, J. Blouin, and R. Landau Observational study of the effect of mu-opioid receptor genetic polymorphism on intrathecal opioid labor analgesia and post-cesarean delivery analgesia Int J Obstet Anesth 19 3 2010 246 253
110. Q. Wu, P.Y. Law, L.N. Wei, and H.H. Loh Post-transcriptional regulation of mouse mu opioid receptor (MOR1) via its 3′ untranslated region: a role for microRNA23b FASEB J 22 12 2008 4085 4095
111. W.D. Wu, Y. Wang, Y.M. Fang, and H.Y. Zhou Polymorphism of the micro-opioid receptor gene (OPRM1 118A>G) affects fentanyl-induced analgesia during anesthesia and recovery Mol Diagn Ther 13 5 2009 331 337
112. X. Xuei, L. Flury-Wetherill, L. Bierut, D. Dick, J. Nurnberger Jr., and T. Foroud et al. The opioid system in alcohol and drug dependence: family-based association study Am J Med Genet B Neuropsychiatr Genet 144B 7 2007 877 884 (Pubitemid 47547987)
113. Y. Zhang, D. Wang, A.D. Johnson, A.C. Papp, and W. Sadee Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G J Biol Chem 280 38 2005 32618 32624 (Pubitemid 41368304)
114. H. Zhang, X. Luo, H.R. Kranzler, J. Lappalainen, B.Z. Yang, and E. Krupitsky et al. Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence Hum Mol Genet 15 6 2006 807 819 (Pubitemid 43338224)
115. L. Zhang, K.S. Kendler, and X. Chen The mu-opioid receptor gene and smoking initiation and nicotine dependence Behav Brain Funct 2 2006 28
116. W. Zhang, Y.Z. Chang, Q.C. Kan, L.R. Zhang, H. Lu, and Q.J. Chu et al. Association of human micro-opioid receptor gene polymorphism A118G with fentanyl analgesia consumption in Chinese gynaecological patients Anaesthesia 65 2 2010 130 135
117. W. Zhang, J.J. Yuan, Q.C. Kan, L.R. Zhang, Y.Z. Chang, and Z.Y. Wang Study of the OPRM1 A118G genetic polymorphism associated with postoperative nausea and vomiting induced by fentanyl intravenous analgesia Minerva Anestesiol 77 1 2011 33 39
118. S.T. Zwisler, T.P. Enggaard, L. Noehr-Jensen, S. Mikkelsen, C. Verstuyft, and L. Becquemont et al. The antinociceptive effect and adverse drug reactions of oxycodone in human experimental pain in relation to genetic variations in the OPRM1 and ABCB1 genes Fundam Clin Pharmacol 24 4 2010 517 524
119. S.T. Zwisler, T.P. Enggaard, S. Mikkelsen, C. Verstuyft, L. Becquemont, and S.H. Sindrup et al. Lack of Association of OPRM1 and ABCB1 Single-Nucleotide Polymorphisms to Oxycodone Response in Postoperative Pain J Clin Pharmacol 2011